Montchanin Asset Management’s AbbVie ABBV Stock Holding History

Montchanin Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.25M	Hold	4,955	–	–	1.27%	22
2026 Q1	$1.08M	Buy	+4,955	New	+$1.1M	1.15%	22
2024 Q4	$854K	Hold	4,805	–	–	0.83%	25
2024 Q3	$949K	Hold	4,805	–	–	0.87%	25
2024 Q2	$824K	Hold	4,805	–	–	0.78%	28
2024 Q1	$875K	Buy	+4,805	New	+$828K	0.86%	26
2023 Q2	$715K	Hold	5,305	–	–	0.82%	29
2023 Q1	$845K	Hold	5,305	–	–	1.07%	24
2022 Q4	$857K	Hold	5,305	–	–	1.17%	21
2022 Q3	$712K	Hold	5,305	–	–	1.01%	23
2022 Q2	$813K	Buy	+5,305	New	+$811K	1.13%	20

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Montchanin Asset Management's ABBV Position: Q2 2026 in Review

Montchanin Asset Management held its AbbVie (ABBV) position steady in Q2 2026 at 4,955 shares worth $1.25M. The position accounts for 1.27% of the portfolio, ranked #22.

Montchanin Asset Management first reported a position in ABBV in Q2 2022 and has held it in 11 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Montchanin Asset Management held 4,955 shares of AbbVie worth $1.25M as of Q2 2026.
Montchanin Asset Management left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 1.27% of Montchanin Asset Management's portfolio in Q2 2026, its #22 holding.
Montchanin Asset Management first reported a position in AbbVie in Q2 2022 and has held it in 11 quarters since.
4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Montchanin Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.